Recent news on Idamycin

Analysis: Shake-up in the leukemia market  Oct 16, 2006
16 (UPI) -- An analyst report projects Pfizer's acute myeloid leukemia treatment Idamycin will lose its top spot to Wyeth's Mylotarg and Genzyme/Bioenvision's ... -United Press International Increased Use of Wyeth's Mylotarg and Launches of New Drugs Will ...  Oct 16, 2006
...finds that the current market leader in the United States, Japan, France, Germany, Italy, Spain, and the United Kingdom -- Pfizer's Idamycin/Zavedos -- will ... -PR Newswire (press release), UPDATE 1-Pfizer, Teva settle patent fight over two drugs  -  Nov 21, 2006
ReutersO: Quote, Profile, Research) resolved patent litigation over Teva's sale of generic versions of Pfizer's Zithromax antibiotic and Idamycin cancer medication ...

Teva, Pfizer settle 2 lawsuits  -  Nov 21, 2006
Ynetnews,...ending two lawsuits. The disputes concerned Pfizer's cancer medication Idamycin, and its antibiotic Zithromax. Under the settlement ...

Teva to pay up to 70 mln usd to Pfizer to settle 2 patent lawsuits  -  Nov 21, 2006
Euro2day,Industries Ltd will pay it as much as 70 mln usd to settle two separate lawsuits alleging patent infringement of Pfizer''s cancer medication, Idamycin, and its ...

Pfizer Patent Dispute Settled  -  Nov 22, 2006
Hartford Courant,...has reached an agreement with Teva Pharmaceutical Industries Ltd. to end patent litigation involving the cancer drug Idamycin and the antibiotic Zithromax. ...

Pfizer Announces Settlement with Teva on Patents Covering Cancer ...  -  Nov 22, 2006
ag-IP-news Agency,...agreement with generic drug manufacturer Teva that resolves two separate lawsuits alleging patent infringement of Pfizer's cancer medication, Idamycin, and its ...

Pfizer Ends Suit Against Teva  -  Nov 21, 2006
Wall Street Journal (subscription),The litigation involved Teva's sale of active ingredients of the cancer drug Idamycin and the antibiotic Zithromax. Under the agreement ...

Teva, Pfizer Reach Patent Deal  -  Nov 21, 2006
TheStreet.com...an antibiotic. Idarubicin is sold under the brand name Idamycin by Pfizer. The company markets azithromycin as Zithromax. Teva will ...

Pfizer, Teva Settle 2 Lawsuits  -  Nov 21, 2006
Forbes,...lawsuits. The disputes concerned Pfizer (nyse: PFE - news - people )'s cancer medication Idamycin, and its antibiotic Zithromax. ...

Pfizer settles patent suits against Teva  -  Nov 21, 2006
Crain's New York Business,...agreed to pay Manhattan-based Pfizer up to $70 million and will not challenge the validity of Pfizer’s patents for its anti-cancer drug, Idamycin, and its ...

Pfizer, Teva settle patent fight  -  Nov 21, 2006
ReutersQuote, Profile, Research) have resolved patent litigation over Teva's sale of generic versions of Pfizer's Zithromax antibiotic and Idamycin cancer medication ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional